SB-357134 is a drug which is used in scientific research. It acts as a potent selective and orally active 5-HT6 receptor antagonist. SB-357134 and other 5-HT6 antagonists show nootropic effects in animal studies and have been proposed as potential novel treatments for cognitive disorders such as schizophrenia and Alzheimer’s disease.
This page contains content from the copyrighted Wikipedia article "SB-357134"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
